Close Menu

NEW YORK – Bio-Techne and Uman Diagnostics, a subsidiary of Quanterix, today announced a strategic license and supply agreement for antibodies used in the quantification of neurofilament light (Nf-L) on Bio-Techne's Ella immunoassay platform.

Under the terms of the agreement, Umeå, Sweden-based Uman will supply Nf-L antibodies for use in Minneapolis-based Bio-Techne's Simple Plex immunoassays running on Ella, the firms said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.